Dr. Reddy's Laboratories Hyderabad
GPTKB entity
Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Erez_Israeli
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedBy |
gptkb:Kallam_Anji_Reddy
|
| gptkbp:foundedYear |
1984
|
| gptkbp:headquartersLocation |
gptkb:Hyderabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dr. Reddy's Laboratories Hyderabad
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:ISIN |
INE089A01023
|
| gptkbp:listedOn |
gptkb:NYSE
gptkb:NSE BSE |
| gptkbp:numberOfEmployees |
~24,000
|
| gptkbp:parentCompany |
gptkb:Dr._Reddy's_Laboratories
|
| gptkbp:products |
Active pharmaceutical ingredients
Generic drugs Biosimilars |
| gptkbp:revenue |
INR 24,588 crore (FY 2023)
|
| gptkbp:stockExchange |
gptkb:NYSE
gptkb:NSE BSE |
| gptkbp:stockSymbol |
gptkb:DRREDDY
|
| gptkbp:subsidiary |
Betapharm Arzneimittel GmbH
Dr. Reddy's Laboratories Inc. |
| gptkbp:website |
https://www.drreddys.com/
|
| gptkbp:bfsParent |
gptkb:Madhapur,_Hyderabad
|
| gptkbp:bfsLayer |
7
|